Acetylcholine is the main neurotransm~tter of the efferent auditory system (for review see Eybahn, 1993) that leeds back from the superior olivary complex to the cochlea. This neurotransmitter mediates slow metabotropic effects within target cells, via the activation of the muscarinic receptors (for reviews see Nathanson, 1987 : Hulme el al., 1990 Hosey, 1992) . Their presence m the cochlea has been clearly demonstrated by both binding (James et al., 1983; Whipple and Drescher, 1984 : van Megen et al., 1988) and functional studms (Guiramand el al., 1990; Bartolami el al., 1990 , 1992a : Niedzielsky et al., 1992 . These latter investigations demonstrated that the *To v, hom correspondence should be addressed Dr S. Bartolanal, Laboratolre de Neurophyslologm Sensorlelle, Unl~crsltd Montpelher 1I, Place Eugene Batalllon, 34095 Montpelher, Cedex 5. France 4hbrel mlron.s AF-DX 116, I 1-((2-((dmlhylamlnoI-methyl)-I -plperldlnyl)acetyl)-5, 11 -dihydro-6H-pyrido(2,3-b)-(l,4)-benzodiazepme-6 one: B ....... maximum concentratmn of blndmg site; 4-DAMP, 4-dlphenylacetoxy-N-methyl plperldlne methiodide: lPs, inosltol phosphates, Kj, dissociation constant at equilibrium : K,, lnhlbmon constant at equlhbrmm ; QNB, qumuchdinyl benzylate. muscarinic receptors are linked to the inosltol phosphate (IP) signalling pathway. M3 muscannic receptors have been characterized in the 12-day-old rat cochlea (Guiramand et al., 1990 : Bartolami et al., 1992a and experiments using the polymerase chain reaction have identified mRNAs encoding for m l, m3 and m5 subtypes of muscarinic receptor in the mouse cochlea (Drescher et al., 1992) . The former two molecular forms of the cDNA-cloned receptors correspond to the M1 and M3 receptors, defined in functional studies by means of selective antagonists (Bonnet, 1989; Hulme et al., 1990) During postnatal cochlear development, the activation of muscarlnic receptors is characterlsed by a transient enhancement of the stimulated IP synthesis which peaks at day 12 (Bartolami el al., 1990 (Bartolami el al., , 1992a . The transient increase of the IP response occurs concomitantly with both the formation of the efferent synapses on the outer hair cells (Lenoir et al., 1980; Simmons et al., 1990 ; Cole and Robertson, 1992) and the onset of physiological maturation of the cochlea (Uzlel et al., 1981 ; Puel and Umel, 1987; Lenoir and Puel, 1987; Rybak et al., 1992) . Since a similar correlation between a muscarinic receptor activated IP synthesis and the efferent synaptogenesis has been observed in the bird cochlea (Bartolami et al., 1992b) . These findings suggest that the IP turnover coupled to muscarinic receptors may be implicated in the functional maturation of the cochlea. In addition, the transient peak of the IP synthesis m response to activation of cholinoceptors is concomitant with a period at which outer hair cells are hypersensitive to ototoxicity induced by aminoglycoside antibiotics (Pujol, 1986 ). This suggests a relationship between the anainoglycoside toxicity and the activation of the IP metabohsm (Schacht, 1976 (Schacht, , 1986 Bartolami et al., 1993) .
Altogether these observations indicate that the developmental pattern of the stimulation of muscarinic receptors is of importance for the physiology and pathophysiology of the cochlea. In the present study, we investigate whether the transient enhancement of the muscarinic receptor activated IP synthesis was due to developmental changes in binding properties of muscarinic receptors in the cochlea. The high affinity, but nonetheless non-specific antagonist quinuclidinyl benzylate (Yamamura and Snyder, 1974) was used to determined the concentration and affinity of muscarinic receptors in developing and adult rat cochleas. In addition, the binding sites were pharmacologically characterized using the selective antagonists pirenzepine. AF-DX 116 and 4-DAMP, respectively specific for M1, M2 and M3 muscarinlc receptors (Hammer ctal., 1980 ; Ladinsky et al., 1988 ; Barlow et al., 1990) . This study particularly focuses on three stages: 4-day-old, 12-day-old and adult which are representative of the three phases of the developmental profile of the muscarinlc receptor activated IP synthesis, The first stage corresponds to the onset of the inositol phosphate response, the second one to the peak response, and third one to maturity of the response (Bartolami et al., 1990~ 1992a .
EXPERIMENTAL PROCEDURES

AlaterutLs
Trltated qulnuchdlnyl benzylate (QNB, speclliC activity' 45.4 Ci mmol) was purchased from New England Nuclear Boston, MA, atropine and plrenzepine from Sigma Chemical Co, St Louis MO and 4-dlphenylacetoxy-N-methyl plperldine methlodlde (4-DAMPI from Research Biochemical Inc. Natlck, MA. Bovine serum albumin was obtained from Boerhlnger Mannhelm, Indianapolis, IN and l l-((2-((dlethylatnlnol -methyl)-1 -plperldlnyl)acetyl) -5,11 -dlhydro -6H-pyrldo(2,3-b)-(1,4)-benzodiazeplne-6 one (AF-DX 116) was a gift from Boehringer lngelheim (Reims, France). All other compounds were of analytical grade.
Dis.section ol the cochleas
Adult, [2 find 4-day-old Wlstar rats were stunned and killed by decapitation. The cochleas were quickly dissected out from the temporal bones, the stria ~,ascularls were removed and the cochleas were collected in ice-cold phosphate buffered saline pH 7.4 (PBS 50 mM Na,HPO~ 50 mM KH.,PO4 125 mM NaCI). The dissected cochleas were then composed of the organ of Corti, the spiral ganglion and the modiolus that contains the distal (peripheral) segment of the cochlear nerve.
Membrane pr¢Taralton
The dissected cochleas were washed 4 times with PBS at 0 4 C and then homogenized in PBS using an all glass homogenizer at the concentration of 12 cochleas/ml. The resulting homogenates were centrifuged at 300 j., for 10 rain, the supernatants containing the cochlear membranes were taken, and then stored at -70 C before use
As.sa) s o/[ ~H]QNB binding
The method was derived from the technique optimized by Yamamura and Snyder (1974) . Membrane ahquots (320 id) were mixed with 40/A PBS and [~H]QNB at concentrations varying from 0.01 to 5 nM, and then incubated at 25 C for 90 mln. The binding reaction was stopped by filtration of the samples, under vacuum, onto Whatman GF/B filters and by washing the filters with 3 x 4 ml PBS at 0 4 C The amount of [']QN B retalned/'filter was measured by liquid scintillation counting ~lth an efficacy of 50%. This procedure allows the determination of the quantity of total bound QNB. In ordel to measure the non-specific binding, 1 ILM atropine was added to the incubation medium. In this condition, atropine is used at a 1000-fold higher concentration than the QNB concentration find therefore it competitively prevents the binding of QNB to muscarlnlC sites In the presence of atropine, QNB binds soleI~ to non-specific sites. The amount of specific bound QNB was obtained by subtracting the values of the non-specific binding from the total binding. Trials of displacement of the binding of [~H]QNB were conducted by adding the specific, muscarinlc antagonists 4-DAMP (M3), plrenzeplne (MI) and AF-DX 116 (M2) to the reaction medium The results of the binding assays were normalized to the amount of protein present in the membrane preparations, which was measured according to Lowr~ et al (1951) using bowne serum albumin as standard
SlallSllCa/ atla]l'MS arid data expres.~ton
The results were analysed using the LIGAND computer program (Munson and Rodbard, 1980) and were expressed either as ratios of the amount of bound QNB to the quantity of protein contained in the samples (fmol of QNB/mg of protein), or as percentages of the amount of specificall~ bound QNB The data are the lneans±SEM of three individual e~perlments, at least Each experiment ~as performed In duphcate The statistical significance of the data was deternamed using one way ANOVA
RESULTS
Linearity o[ the [ ~H]QNB binding as a/unction o! the concentration o['cochlear membrane
Cochlear membranes obtained from adult, 12 and 4-day-old rat cochleas, were diluted in PBS at concentratlons ranging from 2 to 12 cochleas/ml and used for binding assays with QNB at the concentration of 0.08 nM. The specific QNB binding is linear for concentrations of cochlear membrane ranging from 111 to 186 #g/ml (6 10 cochleas/ml) in the case of adult cochleas, from 57 to 143 /~g/ml (4-I0 cochleas/ml) for the 12-day-old cochleas and from 52 to 317 ttg/nll (2-12 cochleas/ml) for the 4-day-old cochleas (data not shown). The mean amounts (-+SEM) of protein/cochlea are 26.4 4-5.9 #g, 14.3 4-1.8 Itg and 18.6_+2.2 Itg lbr the 4-day-old, 12-day-old and adult cochleas, respectwely.
Saturation of the [ W]QNB binding
Membranes obtained from adult, 12-day-old and 4-day-old rat cochleas were diluted to concentrations of 149, 114 and 211 #g protein/ml respectively (8 cochleas/ml) and incubated with increasing concentrations of ['H]QNB. The saturation curves were established, for each stage of maturation and their respective Scatchard analyses were carried out. From these analyses, the binding constants were obtained (Table I ). The dissociation constants (Kj) are 207-+80 (-+SEM), 42-+ 7 and 28 :t-3 pM for the muscarinic binding sites of the 4-day-old, 12-day-old and adult cochlear membranes, respectively. Each Kd value is significantly different from the other two (P < 0.001) The concentratlons of binding sites (B.,~,) within the 4-dayold, 12-day-old and adult membrane preparations are, respectively, 454 + 51 ( -+ SEM), 39-+ 2 and 42-+ 3 fmol of QN B/mg of protein. The B ...... values of the 12-dayold and adult cochlear membranes are not statistically different. The saturation of the specific binding is reached with concentrations of QNB starting at 0.1 nM in the cases of the adult and 12-day-old cochleas and, 0.5 nM for the 4-day-old cochlea. The Hill coefficients are in all cases less than but close to unity (Table 1 ) .
hlhtbmon o/ the speci#c QNB binding by selective I?llISC(II'InlC anld, qoniAts In this series of experiments, every membrane preparatlon was diluted to the concentration of 6 cochleas/ml. This concentration corresponds to about 111, All the data are means ± SEM of experiments conducted In duphcate The number of expernnent is n and the number of tested QNB concentraUon', experiment ranges from 5 to I I *** different from its corresponding adult parameter with P < 0 001 86 and 158 /tg protein/ml for the adult, 12-day-old and 4-day-old membrane preparations, respectively. The subtype-specific muscarlnlC antagonists pirenzepine (M1), AF-DX 116 (M2) and 4-DAMP (M3) were used to displace the specific QNB binding obtained by incubating the samples of adult and 12-day-old cochlear membranes with 0.08 nM of QNB and the 4-day-old membrane samples with 0.4 nM of QNB. These concentrations of QNB were selected from the saturation study.
As for the adult samples, the subtype-specific antagonists inhibit the specific binding of QNB, that is 38_+9 (_+SEM) fmol of QNB/mg of protein, in a dose-dependent manner ( Fig. 1) with a rank order of potency : 4-DAMP > AF-DX 116 > pirenzeplne (Table 2) The inhibition constants (K,) are significantly different, with P < 0.01 for 4-DAMP:plrenzepine and with P < 0.05 for AF-DX l l6/pirenzepine and 4-DAMP/AF-DX 116.
In the 12-day-old preparation, the specific binding of QNB is 45+ 10 fmol of QNB/mg of protein. It is Inhibited In a dose-dependent manner (Fig. 2) with the following rank order of potency : 4-DAMP > AF-DX 116 = pirenzepine. The h; values (Table 2) The data are means+SEM of experiments conducted In duphcate At least 3 identical experiments were done m each case K, values were calculated by the equatmn of Cheng and Prusoff11973) A, -( I +C/ha) x IC,,, ~,,lth (' being the concentratmn of free QNB, the K,~ valuc~ are given m Table 2 For a gwen developmental stage, K, values are dlfl'elent from the K, value obtained wllh 4-DAMP, wHh P < 0 001 1"**), P < 0 01 (**) and P < 0 05 (*) stgnificantly different for 4-DAMP/AF-DX 116 (P < 0.01) and for 4-DAMP/plrenzepine (P < 0.05). Exposure of the 4-day-old membranes to antagomsts also results m dose-dependent inhibitions of the specific bmding of QNB, that is 479__+28 fmol of QNB/mg protein (Fig. 3) . The relative order of potency is 4-DAMP > AF-DX 116 < plrenzeplne. The K, values of the three antagonists statistically differ (P < 0.001, m every case, Table 2 ). At all stages, the Htll numbers are close to umty, whatever the antagonist (Table 2) .
DISCLSSION
Chan.qes in muscarinic hinding properties are not invoh,ed in the enhanced IP metaholR'm
The affinity of the cochlear muscanmc receptor increases during maturation, while the concentration of receptor decreases with age. When compared with the developmental pattern of the muscarinic receptor activated IP synthesis (Bartolami et al., 1990 (Bartolami et al., , 1992a ), the data demonstrate that binding properties of muscarinic sites and changes in the muscarlnic sttmu- lation of the signalling pathway diverge during maturation of the auditory organ. For instance, the IP synthesis decreases from day 12 to adulthood whereas, during the same period, the receptor affinity increases and the concentration of muscarinic site does not change significantly (Fig. 4) . Likewise, from day 4 to day 12 the IP formation increases while the concentration of muscarimc sites falls drastically (Fig 4) . Such a difference between muscarimc binding propertles and muscarmlc agonist-elicited IP turnover have also been shown during cortical ontogeny (Balduinl et al., 1987 : Heacock etal., 1987 : Rooney and Nahorski, 1987 . This conclusion rules out the possibility that the transient enhancement of the IP response peaking at day 12 (Bartolami et al., 1990 (Bartolami et al., , 1992a , is due to an increase m e~ther the concentration of muscarinic receptors or the affinity of the binding sites.
Pharmacoh¥l.)' o/the hindinq sites
Alternatively, a variation in the receptor phenotype could explain the transient, high IP response. The expression of M3 receptors, characterized at day 12 (Guiramand ¢t al., 1990 : Bartolami et al., 1992a , may decline and switch to the synthesis of muscarlnic Table 1 and the adult mean aftimty value is 38.81 +4.20 nM ~. The IP responses are from Bartolaml et al. (1992a, Fig. 1 ) The IP synthesis was stimulated by carbachol (1 mM), the basal level taken to be 100% of IP formation in adult cochleas is 0 043±0.006 dpm~H-IPs/dpm [~H]myo-lnosltol taken up/ cochlea receptors which are not coupled to phospholipase C, but rather linked to inhibition of adenylyl cyclase such as m2 or m4 receptors (Nathanson, 1987; Bonner, 1989 : Hulme et al., 1990 Hosey, 1992) . However, the possibility of such a change in the muscarinic phenotype can be dismissed because the molecular analysis of mRNAs encoding cochlear muscarinlc receptors did not detect m2 and m4 mRNAs in cochlear cells (Drescher et al., 1992) . Drescher and co-workers (1992) also identified m l, m3 and m5 proteins mRNAs in adult mice cochleas, suggesting the presence of several muscarinic receptor subpopulations. In the present study, the very low affinity of pirenzepme for the binding s~tes argues against the functional expression of MI receptors in the auditory organ. The absence of M I receptors is further supported by an extended characterization which showed that both antagonist and agonist M1 ligands have a low affimty for IP synthesis-coupled muscarlnic receptors in the cochlea (Bartolami et al., 1992a) . As for M5 receptors, the lack of a specific hgand prevents their pharmacological identification. On the other hand, in the present work Hill numbers are close to unity (Tables 1 and 2 ). In agreement with other surveys, this indicates the existence of solely one population of muscarlnlC sites (James et al., 1983 : Whipple and Drescher, 1984 : van Megen et al., 1988 . This population is highly sensitive to 4-DAMP which is at least 15-fold more efficient than AF-DX 116 and plrenzeplne in inhibiting the QNB binding (Table 2) . Therefore, the cochlear muscarinic population is likely of the M3 subtype, as previously reported (Guiramand et al., 1990 : Bartolami et al., 1992a . Together with mRNA analysis (Drescher et al., 1992) , our data suggest that the synthesis of MI and M5 receptors may be regulated posttranscriptlonally. In addition, M3 receptors have a pharmacology proper to the cochlea in that AF-DX 116 is a better antagonist than pirenzepine at the binding sites. Such a profile was also found m ~'ico (Kujawa et al., 1993) and in patchclamp studies using isolated outer hair cells (Kakehata et al., 1993) .
Concerning the muscanmc sites of the 4-day-old cochlea, their pharmacologic profile fits the M3 type but their K,, and K, parameters are much higher than the ones generally obtained with M3 sites. This discrepancy may reflect a possible molecular maturation of muscarinic proteins during cochlear development, as has been shown in the retina (Cho and Klein, 1988) .
Enhancement o/phospholipase C actit'io'
From the previous conclusions, it appears that the transitional peak activation of muscarinic receptors is accounted for by changes in activities of other proteins in the signalling pathway, lying downstream from muscarmic sites. These changes may be clther an increase m the efficacy of coupling between receptors and phospholipases C, as reported in the developing cortex (Balduini et al., 1987~ Heacock et al., 1987 : Rooney and Nahorskl, 1987 or an alteration in the intrinsic actwity of phospholipase C.
Concerning couphng efficiency, besides regulation by anteracting molecules, the improvement of the coupling efficiency could be due to the transitional expression of G proteins that are more potent in stimulating phosphohpases C. Indeed, it has been reported that several G proteins able to activate phosphohpases C with various efficiencies exist (Ashkenazi et al.. 1989 : Lechleiter et al., 1991 . Alternatively, a variation in the turnover of G protein and/or phospholipase C could be involved. This would modify the stoichlometry of interactions between receptors, G proteins and phospholipases C, thus resulting in a greater number of phospholipases C achvated by a single muscarmic receptor.
As for alterations of phosphohpase C intrinsic acuvity, these modulations may be achieved by several mechanisms : ( 1 ) phosphorylation of phospholipase C b~ various kmases (Crooke and Bennet, 1989 : Majerus et al., 1990 , Rhee, 1991 Guillon et al.~ 1992) , some of these kinases being present in the cochlea (Coling and Schacht, 1991) : {2) regulation of the mtracellular calcmm level (Crooke and Bennet, 1989 : Gmllon et a/., 1992); (3) inhibition by phosphollpids such as phosphatidylcholine (Majerus et al., 1986) : (4) regulation of phospholipase C translocation (Lee et al., 19871 and (5) changes in the substrate supply due either to complex formations between substrate molecules and proteins such as alpha actmine, profillne and profilactine (Lassing and Lindberg, 1985: Goldshmidt-Clermont et al., 1990; Fukami et al., 1992) or to alteration of substrate synthesis (Gmllon et al., 1992) . Actually. since an enhancement of the basal IP turnover parallels the transitional rise m the stunulated IP response (Bartolami et al., 1990 (Bartolami et al., , 1992a , an alteration of the intrinsic achvity of phosphohpase C Is favoured with regard to changes in the couphng efficiency.
In summary, the developmental divergcnce between the muscarinic binding properties and the pattern of stimulated IP metabolism suggests that changes in the properttes of muscarinic receptors do not underlie the transaent rise of the inositol phosphate response. Therefore, the transient increase, observed during the maturation of the rat cochlca, in both the basal and muscarinic receptor-mediated synthesis of mos~tol phosphates appears to be likely due to an enhancement of the intrinsic activity of phosphohpase C. 
